Last reviewed · How we verify
Systemic AMG 108 — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Systemic AMG 108 (Systemic AMG 108) — Amgen.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Systemic AMG 108 TARGET | Systemic AMG 108 | Amgen | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Systemic AMG 108 CI watch — RSS
- Systemic AMG 108 CI watch — Atom
- Systemic AMG 108 CI watch — JSON
- Systemic AMG 108 alone — RSS
Cite this brief
Drug Landscape (2026). Systemic AMG 108 — Competitive Intelligence Brief. https://druglandscape.com/ci/systemic-amg-108. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab